1. Home
  2. IMRN vs REBN Comparison

IMRN vs REBN Comparison

Compare IMRN & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • REBN
  • Stock Information
  • Founded
  • IMRN 1994
  • REBN 2015
  • Country
  • IMRN Australia
  • REBN United States
  • Employees
  • IMRN N/A
  • REBN N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • REBN Restaurants
  • Sector
  • IMRN Health Care
  • REBN Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • REBN Nasdaq
  • Market Cap
  • IMRN 15.0M
  • REBN 8.6M
  • IPO Year
  • IMRN N/A
  • REBN 2022
  • Fundamental
  • Price
  • IMRN $1.96
  • REBN $1.32
  • Analyst Decision
  • IMRN Strong Buy
  • REBN
  • Analyst Count
  • IMRN 1
  • REBN 0
  • Target Price
  • IMRN $5.00
  • REBN N/A
  • AVG Volume (30 Days)
  • IMRN 6.1K
  • REBN 94.7K
  • Earning Date
  • IMRN 12-31-2024
  • REBN 11-19-2024
  • Dividend Yield
  • IMRN N/A
  • REBN N/A
  • EPS Growth
  • IMRN N/A
  • REBN N/A
  • EPS
  • IMRN N/A
  • REBN N/A
  • Revenue
  • IMRN $3,271,194.00
  • REBN $5,502,528.00
  • Revenue This Year
  • IMRN N/A
  • REBN $185.18
  • Revenue Next Year
  • IMRN N/A
  • REBN $64.55
  • P/E Ratio
  • IMRN N/A
  • REBN N/A
  • Revenue Growth
  • IMRN 171.67
  • REBN 9.70
  • 52 Week Low
  • IMRN $1.59
  • REBN $0.92
  • 52 Week High
  • IMRN $5.96
  • REBN $8.80
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 45.89
  • REBN 48.72
  • Support Level
  • IMRN $2.05
  • REBN $1.06
  • Resistance Level
  • IMRN $2.23
  • REBN $1.36
  • Average True Range (ATR)
  • IMRN 0.17
  • REBN 0.13
  • MACD
  • IMRN -0.00
  • REBN 0.05
  • Stochastic Oscillator
  • IMRN 29.69
  • REBN 62.79

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an innovative company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

Share on Social Networks: